Companion Society Meetings
International Society of Breast Pathology
Breast Pathology in 2018; Current Concepts and Future Directions
Sunday, March 18, 2018, 7:30 - 10:30 PM
3 CME and 1.5 SAMs
K.P. Siziopikou, MD, PhD, Northwestern University, Chicago, IL
Gelared Farshid, MD, The University of Adelaide, South Australia
The purpose of the companion meeting is to inform the audience about recent changes in the practice of Breast Pathology. The current program will cover the emerging use of precision medicine in breast carcinomas and stromal lesions of the breast. In addition, new guidelines re: state-of-art HER2 testing and future directions will be discussed.
Upon completion of this educational activity, the learner will be able to:
- Understand the emerging role of precision medicine in breast cancer diagnosis and treatment
- Describe the current understanding of the molecular mechanisms that drive the development of the spectrum of fibroepithelial lesions of the breast
- Cite the updated guidelines for HER2 testing and be able to incorporate them in their everyday practice
|7:30 PM||Awardee of the BCRF-Larry Norton Award for Excellence in Breast Pathology|
|8:00 PM||Fibroepithelial Lesions of the Breast
Puay Hoon Tan, MD, Singapore General Hospital, Singapore
|8:30 PM||Precision Medicine in Breast Cancer
Samuel Aparicio, MD, PhD, University of British Columbia, Vancouver, BC, Canada
|9:00 PM||HER2 Testing in 2018 and Beyond
Elizabeth H. Hammond, MD, University of Utah School of Medicine, Salt Lake City, UT
|9:30 PM||Questions and Answers|
Continuing Medical Education and Maintenance of Certification
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The United States and Canadian Academy of Pathology and International Society of Breast Pathology. The United States and Canadian Academy of Pathology is accredited by the ACCME to provide continuing medical education for physicians.
The United States and Canadian Academy of Pathology designates this live activity for a maximum of
3 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The USCAP is approved by the American Board of Pathology (ABP) to offer Self-Assessment credits (SAMs) for the purpose of meeting the ABP requirements for Maintenance of Certification (MOC). Physicians must take and pass the post-test in order to claim SAMs credit.
Physicians can earn a maximum of 1.5 SAM credit hours.